Piperdine derivatives and hypotensives containing the same

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reissue Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S089000, C546S187000, C546S191000, C546S196000, C546S202000, C546S203000, C546S204000, C546S208000, C546S209000, C546S210000, C546S213000, C546S214000

Reissue Patent

active

RE038257

ABSTRACT:

BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
The present invention relates to a piperidine derivative and hypotensives containing the same.
DESCRIPTION OF THE BACKGROUND
It is said that there are about 13,000,000 patients with hypertension in Japan and its frequency of occurrence in individuals becomes greater with advancing age. Further, as the age of a given population increases, increased attention is directed to hypertension which becomes more and more of a dangerous factor in severe heart and cerebral diseases represented by cardiac infarction and cerebral apoplexy. In recent years, calcium antagonists or angiotensin convertase inhibitors have been widely used as excellent primary selection drugs for treatment of hypertension. But the pharmaceutical effects or safety of these hypotensives have recently come into question.
A need therefore continues to exist for new hypotensive agents which exhibit excellent pharmaceutical effects and safety which can be industrially prepared at low cost and in a simple manner.
SUMMARY OF THE INVENTION
Accordingly, one object of the present invention is to provide an effective hypotensive agent which is relatively simple to prepare at low cost.
Briefly, this object and other objects of the present invention as hereinafter will become more readily apparent can be attained by a piperidine derivative of formula (I):
wherein A is a fused aromatic ring; R is hydrogen, chloro or methoxy; X is (CH
2
)
n
, which may be substituted, in which n is 0 or an integer of 1 to 10, —CH≡CH—, —C≡C—, —O—, —S—, —NH—, —N(COCH
3
)—, —N(COOC
2
H
5
)—, —N(CHO)—, —N(CH
3
)—, —CO—, —SO—, or —SO
2
—; Y is —CH≡CH—, —CH
2
CH
2
—, —CH
2
CO—, —O—, —S—, —NH—, —OCH
2
—, —SCH
2
—, —NHCH
2
—, —CH(OH)CH
2
—or —CH (OH) CH (OH) —; and Q is substituted or unsubstituted n-hexyl, carboxypropyl, ethoxycarbonylpropyl, cyanopropyl, cyclohexyl, phenyl, indanyl, naphthyl, tetrahydronaphthyl, benzocycloheptyl, piperidinyl, tetrahydroisoquinolinyl, indolyl, pyrolyl, furyl, thienyl, thiazolyl, oxazolyl or N-methylpyrolyl, wherein any one or more of the —(CH
2
)-groups of the hexyl, carboxypropyl, ethoxycarbonylpropyl and cyanopropyl groups may be replaced by —CH≡CH—, —C≡C—, —O—, —S—, —NH—, —N (COCH
3
), —N(COC
2
H
5
)—, —N(CHO)—, —N(CH
3
)—, —CO—, —SO— or —SO
2
—, and wherein one or more of the —(CH
2
)-groups in X and Q may be substituted by —(CH
2
)
4
— or —(CH
2
)
5
— thereby forming a ring structure.


REFERENCES:
patent: 4031222 (1977-06-01), Remy
patent: 4073912 (1978-02-01), Kaiser et al.
patent: 4356184 (1982-10-01), Deason et al.
patent: 4912222 (1990-03-01), Griffith et al.
patent: 5229400 (1993-07-01), Hirasawa et al.
patent: 5231105 (1993-07-01), Shoji et al.
patent: 005 607 (1979-11-01), None
patent: 1 153 977 (1969-06-01), None
White, Chemical Patent Practice, pp. 240-241, 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Piperdine derivatives and hypotensives containing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperdine derivatives and hypotensives containing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperdine derivatives and hypotensives containing the same will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3060776

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.